餐前乳清蛋白通过增强β细胞功能并降低胰岛素清除率改变2型糖尿病餐后高胰岛素血症
该单盲、随机、安慰剂对照交叉设计研究纳入18例2型糖尿病成人(HbA1c 56.7 ± 8.8 mmol/mol),比较餐前10分钟摄入乳清蛋白(15 g蛋白质)或安慰剂(0 g蛋白质)后240分钟混合餐耐量试验。乳清蛋白使β细胞功能增加40%(P = .001)、餐后胰岛素清除率降低22%(P < .0001),并降低餐后血糖增量曲线下面积16%(P < .05),而胰岛素分泌率未受影响(P = .133)。
要点
- 餐前乳清蛋白使2型糖尿病患者β细胞功能增加40%(P = .001)。
- 餐前乳清蛋白使餐后胰岛素清除率降低22%(P < .0001),胰岛素分泌率未受影响(P = .133)。
- 餐前乳清蛋白降低餐后血糖增量曲线下面积16%及峰值变化-1.5 mmol/L(均P < .05)。
核心结论
- 在2型糖尿病成人中,餐前乳清蛋白通过协同增强β细胞功能与降低胰岛素清除率来降低餐后血糖,从而在不需进一步刺激β细胞的情况下实现高效的餐后胰岛素血症谱。
研究设计与样本
- 单盲、随机、安慰剂对照交叉设计研究,纳入18例2型糖尿病成人(HbA1c 56.7 ± 8.8 mmol/mol),进行2次240分钟混合餐耐量试验。
- 参与者于混合宏量营养素早餐前10分钟摄入乳清蛋白(15 g蛋白质)或安慰剂(0 g蛋白质)。
主要发现
- 乳清蛋白后β细胞功能较安慰剂增加40%(P = .001)。
- 乳清蛋白后餐后胰岛素清除率较安慰剂降低22%(P < .0001)。
- 乳清蛋白降低餐后血糖峰值变化-1.5 mmol/L及餐后血糖增量曲线下面积16%(均P < .05)。
- 餐前乳清蛋白使胰高血糖素和胰高血糖素样肽1的增量曲线下面积增加5.9倍(均P < .0001),胰岛素增量曲线下面积增加1.5倍(P < .001)。
- 尽管乳清蛋白后血浆胰岛素反应更大,胰岛素分泌率未受影响(P = .133)。
关键数值与推荐
- 餐后血糖增量曲线下面积为预设主要终点,胰岛素清除率为事后分析。
- 胰岛素分泌率通过C肽脱卷积计算,胰岛素清除率和β细胞功能由葡萄糖、胰岛素和胰岛素分泌率建模估计。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Treatments that reduce postprandial glycemia (PPG) independent of stimulating insulin secretion are appealing for the management of type 2 diabetes (T2D). Consuming pre-meal whey protein (WP) reduces PPG by delaying gastric emptying and increasing plasma insulin concentrations. However, its effects on β-cell function and insulin kinetics remains unclear. OBJECTIVE: To examine the PPG-regulatory effects of pre-meal WP by modeling insulin secretion rates (ISR), insulin clearance, and β-cell function. METHODS: This was a single-blind, randomized, placebo-controlled, crossover design study in 18 adults with T2D (HbA1c, 56.7 ± 8.8 mmol/mol) who underwent 2 240-minute mixed-meal tolerance tests. Participants consumed WP (15 g protein) or placebo (0 g protein) 10 minutes before a mixed-macronutrient breakfast meal. PPG, pancreatic islet, and incretin hormones were measured throughout. ISR was calculated by C-peptide deconvolution. Estimates of insulin clearance and β-cell function were modeled from glucose, insulin, and ISR. Changes in PPG incremental area under the curve (iAUC; prespecified) and insulin clearance (post hoc) were measured. RESULTS: β-cell function was 40% greater after WP (P = .001) and was accompanied with a -22% reduction in postprandial insulin clearance vs placebo (P < .0001). Both the peak change and PPG iAUC were reduced by WP (-1.5 mmol/L and -16%, respectively; both P < .05). Pre-meal WP augmented a 5.9-fold increase in glucagon and glucagon-like peptide 1 iAUC (both P < .0001), and a 1.5-fold increase in insulin iAUC (P < .001). Although the plasma insulin response was greater following WP, ISR was unaffected (P = .133). CONCLUSION: In adults with T2D, pre-meal WP reduced PPG by coordinating an enhancement in β-cell function with a reduction in insulin clearance. This enabled an efficient postprandial insulinemic profile to be achieved without requiring further β-cell stimulation.Trial registry ISRCTN ID: ISRCTN17563146 Website link: www.isrctn.com/ISRCTN17563146.
引用
- Smith K, Taylor GS, Walker M, et al. Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing β-Cell Function and Reducing Insulin Clearance in T2D. J Clin Endocrinol Metab. 2023. PMID: 36734166. doi:10.1210/clinem/dgad069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。